These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 11431340

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [Abstract] [Full Text] [Related]

  • 6. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
    Wang CY, Jones RF, Debiec-Rychter M, Soos G, Haas GP.
    Anticancer Res; 2002 Jan; 22(6B):3529-35. PubMed ID: 12552951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk.
    Henning S, Cascorbi I, Münchow B, Jahnke V, Roots I.
    Pharmacogenetics; 1999 Feb; 9(1):103-11. PubMed ID: 10208649
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC.
    Cancer Res; 1995 Aug 15; 55(16):3537-42. PubMed ID: 7627961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I, Németh A, Bogner B, Pajkos G, Orsós Z, Sándor J, Csejtey A, Faluhelyi Z, Rodler I, Ember I.
    Anticancer Res; 2004 Aug 15; 24(6):3965-70. PubMed ID: 15736440
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer].
    Hao GY, Zhang WD, Chen YH, Zhang DX, Zhang YH.
    Zhonghua Zhong Liu Za Zhi; 2004 May 15; 26(5):283-6. PubMed ID: 15312364
    [Abstract] [Full Text] [Related]

  • 16. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
    Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, Golka K, Okkels H, Risch A, Rothman N, Sim E, Taioli E.
    Cancer Epidemiol Biomarkers Prev; 2001 Dec 15; 10(12):1249-52. PubMed ID: 11751441
    [Abstract] [Full Text] [Related]

  • 17. Polymorphism in the N-acetyltransferase 1 alleles NAT1*10 and NAT1*14A and cytological gradings of exfoliated urothelial cells in benzidine-exposed Chinese workers: discussion of ethnic differences.
    Guo WC, Lin GF, Chen JG, Golka K, Shen JH.
    Arch Toxicol; 2004 Aug 15; 78(8):425-9. PubMed ID: 15197537
    [Abstract] [Full Text] [Related]

  • 18. Para-phenylenediamine and allergic sensitization: risk modification by N-acetyltransferase 1 and 2 genotypes.
    Blömeke B, Brans R, Coenraads PJ, Dickel H, Bruckner T, Hein DW, Heesen M, Merk HF, Kawakubo Y.
    Br J Dermatol; 2009 Nov 15; 161(5):1130-5. PubMed ID: 19663877
    [Abstract] [Full Text] [Related]

  • 19. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Yu MC.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun 15; 9(6):619-23. PubMed ID: 10868698
    [Abstract] [Full Text] [Related]

  • 20. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J, Cascorbi I, Kerb R, Roots I.
    Cancer Res; 1996 Sep 01; 56(17):3915-25. PubMed ID: 8752158
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.